LDN works by blocking opioid receptors briefly, which temporarily increases the body's production of endorphins. This mechanism is thought to modulate immune response and reduce inflammation, contributing to its therapeutic effects in diverse conditions.
Low Dose Naltrexone (LDN) has indeed shown promise in the treatment of various chronic conditions, particularly those involving immune system dysregulation and inflammation.